help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arai, K.
Right arrow Articles by Chrousos, G. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arai, K.
Right arrow Articles by Chrousos, G. P.
The Journal of Clinical Endocrinology & Metabolism Vol. 84, No. 7 2434-2437
Copyright © 1999 by The Endocrine Society


Original Studies

Polymorphisms of Amiloride-Sensitive Sodium Channel Subunits in Five Sporadic Cases of Pseudohypoaldosteronism: Do They Have Pathologic Potential?1

Keiko Arai, Keith Zachman, Tamotsu Shibasaki and George P. Chrousos

Department of Physiology, Nippon Medical School (K.A., T.S.), 1–1-5 Sendagi, Bunkyo-ku, Tokyo 113-8602, Japan; and the Developmental Endocrinology Branch, National Institute of Child Health and Human Development, National Institutes of Health (K.Z., G.P.C.), Bethesda, Maryland 20892

Address all correspondence and requests for reprints to: Keiko Arai, M.D., Department of Physiology, Nippon Medical School, 1–1-5 Sendagi, Bunkyo-ku, Tokyo 113-8602, Japan. E-mail: arai_keiko/phys2{at}nms.ac.jp

Pseudohypoaldosteronism (PHA) is characterized by congenital resistance of the kidney and/or other mineralocorticoid target tissues to aldosterone, resulting in excessive salt wasting. Mineralocorticoid receptor (MR) and postreceptor defects in the aldosterone-responsive amiloride-sensitive sodium channel (ENaC) subunits have been suggested as potential loci of the defect in this disease, whereas recently defects in MR and ENaC subunits were reported in familial PHA cases. Here we studied the ENaC subunit {alpha}, ß, and {gamma} complementary DNAs (cDNAs) in a series of five sporadic cases of PHA, whose MR cDNA contained nonconservative homozygous (C944->T944, Ala241->Val241) and/or a conservative heterozygous substitutions (A760->G760, Ileu180->Val180), which, however, were also present at high frequencies in a control population with apparently normal salt conservation. We found a nonconservative substitution (A2086->G2086, Thr663->Ala663) in the {alpha}ENaC in all five of our patients, two of whom were homozygous and three of whom were heterozygous for this alteration, which was also present in the homozygous and heterozygous form in 31% and 64% of control subjects, respectively. We also found a nonconservative homozygous substitution (C1006->G1006, Pro336->Ara336) in the ßENaC and three nonconservative and conservative homozygous substitutions (T554->A554, Trp178->Arg178; C1526->G1526, Pro501->Ala501; T1862->G1862, Ser614->Ala614) in the {gamma}ENaC of all five of our patients and in a substantial proportion of control subjects. Interestingly, when the patient group was compared to controls, a significantly increased concurrence of the MR and {alpha}ENaC polymorphisms was found in the patients (P < 0.025). We conclude that the changes identified in the cDNA of the three ENaC subunits in the patients with sporadic PHA are polymorphisms, which on their own have no apparent pathophysiological significance. We hypothesize, however, that these polymorphisms might influence salt conservation negatively if they are present concurrently with other genetic defects of the MR or other proteins that participate in sodium homeostasis. The latter would be compatible with a sporadic presentation and digenic or multigenic expression and heredity in PHA.




This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
A. Balsamo, A. Cicognani, M. Gennari, W. G Sippell, S. Menabo, F. Baronio, and F. G Riepe
Functional characterization of naturally occurring NR3C2 gene mutations in Italian patients suffering from pseudohypoaldosteronism type 1
Eur. J. Endocrinol., February 1, 2007; 156(2): 249 - 256.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Lebowitz, R. S. Edinger, B. An, C. J. Perry, S. Onate, T. R. Kleyman, and J. P. Johnson
I{kappa}B Kinase-{beta} (IKK{beta}) Modulation of Epithelial Sodium Channel Activity
J. Biol. Chem., October 1, 2004; 279(40): 41985 - 41990.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A.-M. Nystrom, M.-L. Bondeson, N. Skanke, J. Martensson, B. Stromberg, J. Gustafsson, and G. Anneren
A Novel Nonsense Mutation of the Mineralocorticoid Receptor Gene in a Swedish Family with Pseudohypoaldosteronism Type I (PHA1)
J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 227 - 231.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
F. G. Riepe, N. Krone, M. Morlot, M. Ludwig, W. G. Sippell, and C.-J. Partsch
Identification of a Novel Mutation in the Human Mineralocorticoid Receptor Gene in a German Family with Autosomal-Dominant Pseudohypoaldosteronism Type 1: Further Evidence for Marked Interindividual Clinical Heterogeneity
J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1683 - 1686.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
C. P. Thomas, J. Zhou, K. Z. Liu, V. E. Mick, E. MacLaughlin, and M. Knowles
Systemic Pseudohypoaldosteronism from Deletion of the Promoter Region of the Human {beta} Epithelial Na+ Channel Subunit
Am. J. Respir. Cell Mol. Biol., September 1, 2002; 27(3): 314 - 319.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
O. Bonny and B. C. Rossier
Disturbances of Na/K Balance: Pseudohypoaldosteronism Revisited
J. Am. Soc. Nephrol., September 1, 2002; 13(9): 2399 - 2414.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Saxena, I. Hanukoglu, D. Saxena, R. J. Thompson, R. M. Gardiner, and A. Hanukoglu
Novel Mutations Responsible for Autosomal Recessive Multisystem Pseudohypoaldosteronism and Sequence Variants in Epithelial Sodium Channel {alpha}-, {beta}-, and {gamma}-Subunit Genes
J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3344 - 3350.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
M.-Z. Xue, O. Bonny, S. Morgenthaler, M. Bochud, V. Mooser, W. G. Thilly, L. Schild, and P.-M. Leong-Morgenthaler
Use of Constant Denaturant Capillary Electrophoresis of Pooled Blood Samples to Identify Single-Nucleotide Polymorphisms in the Genes (Scnn1a and Scnn1b) Encoding the {alpha} and {beta} Subunits of the Epithelial Sodium Channel
Clin. Chem., May 1, 2002; 48(5): 718 - 728.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Viemann, M. Peter, J. P. López-Siguero, G. Simic-Schleicher, and W. G. Sippell
Evidence for Genetic Heterogeneity of Pseudohypoaldosteronism Type 1: Identification of a Novel Mutation in the Human Mineralocorticoid Receptor in one Sporadic Case and No Mutations in Two Autosomal Dominant Kindreds
J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 2056 - 2059.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Adachi, K. Tachibana, Y. Asakura, S. Abe, J. Nakae, T. Tajima, and K. Fujieda
Compound Heterozygous Mutations in the {{gamma}} Subunit Gene of ENaC (1627delG and 1570-1G{->}A) in One Sporadic Japanese Patient with a Systemic Form of Pseudohypoaldosteronism Type 1
J. Clin. Endocrinol. Metab., January 1, 2001; 86(1): 9 - 12.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1999 by The Endocrine Society